De novo TANC2 stop-loss variant associated with developmental impairment and drug-resistant epilepsy. Hintermayer MA, Myers KA. Epileptic Disord 2026 Mar 17. doi: 10.1002/epd2.70219.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Hintermayer MA, Myers KA. De novo TANC2 stop-loss variant associated with developmental impairment and drug-resistant epilepsy. Epileptic Disord 2026 Mar 17. doi: 10.1002/epd2.70219.
PMID: 41843419